Results 181 to 190 of about 43,902 (289)

Gestione clinica della terapia con Denosumab: in chi, quando e come interromperla [PDF]

, 2023
Stella Pigni, Gherardo Mazziotti
openalex   +1 more source

Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis

, 2010
B Jönsson, O. Ström, John A. Eisman, Αλεξάνδρα Παπαϊωάννου, Ethel S. Siris, Anna N.A. Tosteson, J. A. Kanis   +6 more
openalex   +1 more source

Real-world Management of Women with Postmenopausal Osteoporosis Treated with Denosumab: A Prospective Observational Study in the Czech Republic and Slovakia [PDF]

, 2018
Olga Růžičková, Zdenko Killinger, Petr Kasalický, Lisa Hamilton, Roman Tyl, Soňa Tomková, L. Kalouche-Khalil   +6 more
openalex   +1 more source

What\u27s new in orthopaedic trauma [PDF]

, 2013
Gardner, Michael, McAndrew, Christopher, Ricci, William M, Spiguel, Andre   +3 more
core   +2 more sources

Denosumab Therapy for Giant-cell Tumor of the Lumbar Spine: A Case Report and Immunohistochemical Examination.

, 2020
Takafumi Yayama, Kanji Mori, Akira Nakamura, Tomohiro Mimura, Shinji Imai   +4 more
openalex   +2 more sources

Denosumab for the prevention of skeletal complications in metastatic castration-resistant prostate cancer: comparison of skeletal-related events and symptomatic skeletal events [PDF]

, 2015

openalex   +1 more source

Analysis of the efficacy and safety of denosumab in the treatment of patients with osteoporotic vertebral compression fractures after PVP. [PDF]

Sci Rep
Jiang Y, He B, Shang Q, Liu H, Chen W, Zhao W, Shen G, Ren H, Jiang X.   +8 more
europepmc   +1 more source

Denosumab: A Useful Addition to the Armamentarium for the Management of Male Osteoporosis [PDF]

Jijith Krishnan, Sham Santhanam, Bhuwan Singh, Salim Patel, Divya Bhojwani, Sameer Muchhala   +5 more
openalex   +1 more source

Efficacy of denosumab versus alendronate for aromatase inhibitor-associated osteoporosis in postmenopausal breast cancer patients: a retrospective analysis. [PDF]

BMC Musculoskelet Disord
Zhang Y, Cui W, Hou L.
europepmc   +1 more source

Treatment with denosumab reduces second hip fracture risk in elderly patients with osteoporotic femoral neck fractures. [PDF]

BMC Musculoskelet Disord
Wang Y, Pan K, Li X, Lv Q, Shao Y, Cao L.   +5 more
europepmc   +1 more source